Ganesh Venkataraman Kaundinya, Senior V.P, Research at MOMENTA PHARMACEUTICALS INC (MNTA), sold 384 shares at $16.00 ($6K) on 2017-05-10, disclosed to the SEC on 2017-05-12.
Scheduled sale ($6k) by Senior V.P, Research under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MNTA | SELL | 2018-08-10 | $18K | — | Filing → |
| MNTA | SELL | 2018-05-23 | $9K | — | Filing → |
| MNTA | SELL | 2018-05-14 | $8K | — | Filing → |